913
Arvindakshan, M.; Sitasawad, S.; Debsikdar, V.; Ghate, M.; Evans, D.; Horrobin, D.F.; Bennett, C.N.; Ranjekar, P.K.; Mahadik, S.P. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients
Biol Psychiatry 2003; 53(1): 56-64. (Abstract)
914
Bennett, C.N. and Horrobin, D.F. Locations of genes for phospholipid- and fatty acid-related proteins as compared to those associated with psychiatric disorders
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 599-620.
915
Bennett, C.N. and Horrobin, D.F. Impaired niacin flushing in schizophrenia: possible mechanisms of action.
Presented at: International Congress on Schizophrenia Research, Colorado Springs, Colorado, USA, March 29- April 2, 2003. 2003.
916
Fox, H.; Ross, B.M.; Tocher, D.; Horrobin, D.F.; Glen, I.; St. Clair, D. Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20øC proceeds faster in patients with schizophrenia when compared with healthy controls
Prostaglandins Leukot Essent Fatty Acids 2003; 69(5): 291-7. (Abstract)
917
Horrobin, D.F. Omega-3 Fatty acid for schizophrenia [letter]
Am J Psychiatry 2003; 160(1): 188-9. (Full text)
918
Horrobin, D.F. Why do we not make more medical use of nutritional knowledge?
British Journal of Nutrition 2003; 90: 233-8. (Abstract)
919
Horrobin, D.F. Phospholipid and fatty acid biochemistry in schizophrenia
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 123-62.
920
Horrobin, D.F. The effects of antipsychotic drugs on membrane phospholipids: a possible novel mechanism of action of clozapine
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 271-6.
921
Horrobin, D.F. Eicosapentaenoic acid derivatives in the management of schizophrenia
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 371-6.
922
Horrobin, D.F. Roles of abnormalities of phospholipid metabolism in bipolar disorder
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 409-14.
923
Horrobin, D.F. A speculative overview: the relationship between phospholipid spectrum disorders and human evolution
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 621-40.
924
Horrobin, D.F. A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels
Med Hypotheses 2003; 60(5): 615-23. (Abstract)
925
Horrobin, D.F. Modern biomedical research: an internally self-consistent universe with little contact with medical reality?
Nature Reviews Drug Discovery 2003; 2: 151-4. (Abstract)
926
Horrobin, D.F. The effects on plasma, red cell and platelet fatty acids of taking 12g/day of ethyl-eicosapentaenoate for 16 months dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to inuit metabolism
Prostaglandins Leukot Essent Fatty Acids 2003; 68: 301-4. (Abstract)
927
Horrobin, D.F. The role of dietary fat in bone and joint health
Prostaglandins Leukot Essent Fatty Acids 2003; 68: 359.
928
Horrobin, D.F. Not in the genes. Enthusiasts for genomics have corrupted scientific endeavour and undermined hopes of medical progress
The Guardian 2003; (12 February). (Full text)
929
Horrobin, D.F. Are large clinical trials in rapidly lethal diseases usually unethical?
The Lancet 2003; 361(9358): 695. (Abstract)
930
Horrobin, D.F. and Bennett, C.N. Phospholipid metabolism and the pathophysiology of psychiatric and neurological disorders
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 3-47.
931
Horrobin, D.F. and Bennett, C.N. Peroxisome-proliferator activated receptors (ppar): possible involvement in schizophrenia
Presented at: International Congress on Schizophrenia Research, Colorado Springs, Colorado, USA, March 29 - April 2, 2003 2003.
932
Horrobin, D.F.; Fokkema, M.R.; Muskiet, F.A. The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism.
Prostaglandins Leukot Essent Fatty Acids 2003; 68(5): 301-4. (Abstract)
933
Lynch, M. and Horrobin, D.F. The role of phospholipid metabolism during brain aging and radiation-induced neurodegeneration
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 589-96.
934
Manku, M.S. and Horrobin, D.F. Phospholipids and fatty acid metabolism in schizophrenia and depression
In: Nutrition and Biochemistryof Phospholipids. Szuhaj, B.F. and van Nieuwenhuyzen, W. (Eds.), AOCS Press, Illinois 2003: 40-9.
935
Peet, M.; Edwards, R.W.; Horrobin, D.F. N-3 fatty acids in the treatment of depression
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 463-7.
936
Peet, M. and Horrobin, D.F. The relationship between depression and mental illness
In: Peet, M.; Glen, I.; and Horrobin, D.F. (Eds.) Phospholipid spectrum disorder in psychiatry and neurology (2nd edn.), Marius Press, Carnforth. ISBN: 1-871622-25-5 2003: 431-45.
937
Song, C.; Li, X.W.; Leonard, B.E.; Horrobin, D.F. Effects of dietary n-3 or n-6 fatty acids on interleukin-1 beta-induced anxiety, stress and inflammatory responses in rats.
J Lipid Res 2003; 44(10): 1984-91. (Full text)(Abstract)